Biomedical Research | Sanford Burnham Prebys
Matthew PETROSKI | Sanford Burnham Prebys Medical Discovery Institute, California | Signal Transduction Research Program | Research profile
Matthew PETROSKI | Sanford Burnham Prebys Medical Discovery Institute, California | Signal Transduction Research Program | Research profile
Matthew PETROSKI | Sanford Burnham Prebys Medical Discovery Institute, California | Signal Transduction Research Program | Research profile
Biomedical Research | Sanford Burnham Prebys
Matthew PETROSKI | Sanford Burnham Prebys Medical Discovery Institute, California | Signal Transduction Research Program | Research profile
Matthew PETROSKI | Sanford Burnham Prebys Medical Discovery Institute, California | Signal Transduction Research Program | Research profile
Matt Petroski - Senior Principal Scientist/Lab Head - Pfizer | LinkedIn
Matthew PETROSKI | Sanford Burnham Prebys Medical Discovery Institute, California | Signal Transduction Research Program | Research profile
Matthew PETROSKI | Sanford Burnham Prebys Medical Discovery Institute, California | Signal Transduction Research Program | Research profile
Matthew PETROSKI | Sanford Burnham Prebys Medical Discovery Institute, California | Signal Transduction Research Program | Research profile
Sanford-Burnham scientists unravel cancer dru | EurekAlert!
Matt Petroski - Senior Principal Scientist/Lab Head - Pfizer | LinkedIn
PDF) Bifunctional Apoptosis Regulator (BAR), an Endoplasmic Reticulum (ER)-associated E3 Ubiquitin Ligase, Modulates BI-1 Protein Stability and Function in ER Stress
Matthew PETROSKI | Sanford Burnham Prebys Medical Discovery Institute, California | Signal Transduction Research Program | Research profile
Matthew PETROSKI | Sanford Burnham Prebys Medical Discovery Institute, California | Signal Transduction Research Program | Research profile
Matthew PETROSKI | Sanford Burnham Prebys Medical Discovery Institute, California | Signal Transduction Research Program | Research profile
Adapted ATPase domain communication overcomes the cytotoxicity of p97 inhibitors
Matthew PETROSKI | Sanford Burnham Prebys Medical Discovery Institute, California | Signal Transduction Research Program | Research profile
Matthew PETROSKI | Sanford Burnham Prebys Medical Discovery Institute, California | Signal Transduction Research Program | Research profile
TXNRD1 Mediated Regulation of the Wnt/β-catenin Pathway in Colorectal Cancer | Sanford Burnham Prebys
Matt Petroski - Senior Principal Scientist/Lab Head - Pfizer | LinkedIn
Matt Petroski - Senior Principal Scientist/Lab Head - Pfizer | LinkedIn
Matt Petroski and Jeff Rodvold | Sanford Burnham Prebys
Sanford Burnham Prebys Cancer Center by Sanford Burnham Prebys - Issuu
